JSJacob S. Shaw

Jacob S. Shaw

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jacob S. Shaw has a total of 111 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Associations Between Motor Symptoms and Mild Behavioral Impairment Domains in Autopsy-Confirmed Alzheimer Disease

    by Jacob S. Shaw, Emma S. Shaw, Michael Johnathan Charles Bray, Paul B. Rosenberg, Matthew E. Peters

  • Association Between Menopausal Hormone Therapy and Alzheimer Disease Neuropathology

    by Jennifer Bruno, Jacob S. Shaw, S.M. Hadi Hosseini, For Alzheimer'S Disease Neuroimaging Initiative

    Background and ObjectivesAlthough evidence suggests that the neurophysiologic impact of estrogen decline during menopause may contribute to increased risk of Alzheimer disease (AD) in women, the ef...


  • Relationship between new-onset falls and neuroimaging markers of Alzheimer's disease in the UK Biobank

    by Jacob S. Shaw, Michael J.C. Bray, Haris I. Sair, Licia P. Luna, Katherine J. Hunzinger, Esther S. Oh, Paul B. Rosenberg, Matthew E. Peters

    Background: While Alzheimer's disease (AD) is a known risk factor for falls, the association between falls and incident AD is a growing area of study. Objective: The primary aim of this analysis was to examine associations between new-onset falls in older adults and neuroimaging and plasma biomarkers of AD. A secondary aim was to evaluate associations between new-onset falls and neuroimaging markers of motor dysfunction. Methods: Data from the UK Biobank study was utilized. Participants were 70 years of age or older at the date of neuroimaging and had no reported history of falls at study enrollment. To determine falls status, participants self-reported data on falls history within the last year prior to neuroimaging. Results: 15,447 individuals were included in our analysis (No falls, N = 12,522; One fall, N = 2,199, Multiple falls, N = 726). Compared to individuals in the No falls group, individuals in the One fall and Multiple falls group had significantly higher volumes of white matter hyperintensities, while individuals in the Multiple falls group had significantly lower left and right hippocampal volumes. One or more fall was associated with higher plasma levels of pTau181, which did not remain significant after adjusting for multiple comparisons. Plasma amyloid-β 42/amyloid-β 40 ratio did not differ significantly between groups. Conclusions: In a sample of older adults without history of falls at study enrollment, new-onset falls were associated with decreased hippocampal volumes, which is associated with prodromal AD, as well as an increased volume of white matter hyperintensities, which may also emerge secondary to AD pathology.

  • The impact of traumatic brain injury on sleep and associated neuroimaging changes: A systematic review

    by Jacob S. Shaw, Kaylee Woodard, Akshay Krieg, Barry R. Bryant, Sabrina Kentis, Aaron I. Esagoff, Anne Reisch, Rachel M. Salas, Matthew E. Peters, Michael J.C. Bray


  • Open Access

    Encountering technology: a qualitative exploration of the technology experiences of people living with dementia and their care partners to inform knowledge, practice and technology design

    by Neve Notley, Peter Worthy, Matthew E. Peters, Jacob Shaw, Andrea Nelson, Dennis Frost, Eileen Taylor, Dubhglas Taylor, Janet Wiles, Jacki Liddle


  • Open Access

    Motor symptoms in autopsy‐confirmed Alzheimer's disease increase the risk of progression to severe cognitive impairment

    by Jacob S. Shaw, Philip C. Huang, Paul B. Rosenberg, Matthew E. Peters

    INTRODUCTION: Motor symptoms may present throughout the Alzheimer's disease (AD) course. We evaluated the impact of motor symptoms on the risk of progression to severe cognitive impairment, severe neuropsychiatric symptoms (NPSs), and mortality in patients with autopsy‐confirmed AD. We also examined the rates of non‐AD pathology and identified the predictors of disease progression among these patients.METHODS: Data from the National Alzheimer's Coordinating Center (NACC) were used for this analysis. Participants (N = 1167) were required to have autopsy‐confirmed AD.RESULTS: Motor symptoms were predictive of progression to severe cognitive impairment but not progression to severe NPSs or death. Presenting with gait disturbance and slowness but not falls or tremor was predictive of progression to severe cognitive impairment. Patients with motor symptoms had higher rates of Lewy body disease pathology on autopsy.DISCUSSION: Our findings suggest that the presence of motor symptoms in autopsy‐confirmed AD, particularly gait disturbance and slowness, are predictive of more rapid cognitive decline.Highlights: Clinician‐defined motor symptoms in patients with Alzheimer's disease (AD) predicted more rapid progression to severe cognitive impairment but not to severe neuropsychiatric symptoms (NPSs) or death. Among AD patients with motor symptoms, presenting with gait disturbance and slowness was predictive of progression to severe cognitive impairment, whereas presenting with falls and tremor was not predictive of progression to severe cognitive impairment. Patients with motor symptoms, particularly gait disturbance and slowness, had higher rates of comorbid Lewy body disease pathology.


  • A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension

    by Sabrina Kentis, Jacob S. Shaw, Lisa N. Richey, Lisa Young, Natalia Kosyakova, Barry R. Bryant, Aaron I. Esagoff, Luis F. Buenaver, Rachel Marie E. Salas, Matthew E. Peters

    Sleep disturbances, particularly obstructive sleep apnea (OSA), may have a significant impact on the outcomes of patients with idiopathic intracranial hypertension (IIH). We conducted a PRISMA-compliant systematic literature review to study sleep disturbance in adult patients with IIH. The current literature on the relationship between IIH and sleep is quite limited. Research has found that sleep disturbances are associated with lower quality of life and may worsen several symptoms associated with IIH, such as headache, cognitive deficits, and neuropsychiatric issues. OSA was more prevalent in patients with IIH than in healthy controls. Several studies found that OSA was associated with worse IIH symptoms and treatment of OSA helped improve these parameters. Limitations included available literature and heterogeneity in sleep metrics and OSA diagnostic criteria between studies. Overall, further study of sleep disturbances in patients with IIH may encourage earlier screening, improved treatment options, and long-term improvements in quality of life.


  • Open Access

    Dynamic effects of psychiatric vulnerability, loneliness and isolation on distress during the first year of the COVID-19 pandemic

    by Lauren Y. Atlas, Cristan Farmer, Jacob S. Shaw, Alison Gibbons, Emily P. Guinee, Juan Antonio Lossio-Ventura, Elizabeth D. Ballard, Monique Ernst, Shruti Japee, Francisco Pereira, et al.

    The COVID-19 pandemic’s impact on mental health is challenging to quantify because pre-existing risk, disease burden and public policy varied across individuals, time and regions. Longitudinal, within-person analyses can determine whether pandemic-related changes in social isolation impacted mental health. We analyzed time-varying associations between psychiatric vulnerability, loneliness, psychological distress and social distancing in a US-based study during the first year of the pandemic. We surveyed 3,655 participants about psychological health and COVID-19-related circumstances every 2 weeks for 6 months. We combined self-reports with regional social distancing estimates and a classifier that predicted probability of psychiatric diagnosis at enrollment. Loneliness and psychiatric vulnerability both impacted psychological distress. Loneliness and distress were also linked to social isolation and stress associated with distancing, and psychiatric vulnerability shaped how regional distancing affected loneliness across time. Public health policies should address loneliness when encouraging social distancing, particularly in those at risk for psychiatric conditions.


  • Impact of motor dysfunction on neuropsychiatric symptom profile in patients with autopsy-confirmed Alzheimer’s disease

    by Jacob S. Shaw, Lisa N. Richey, Mia K. Gifford, Michael J.C Bray, Aaron I. Esagoff, Paul B. Rosenberg, Matthew E. Peters

    Motor dysfunction, which includes changes in gait, balance, and/or functional mobility, is a lesser-known feature of Alzheimer's Disease (AD), especially as it relates to the development of neuropsychiatric symptoms (NPS). This study (1) compared rates of NPS between autopsy-confirmed AD patients with and without early-onset motor dysfunction and (2) compared rates of non-AD dementia autopsy pathology (Lewy Body disease, Frontotemporal Lobar degeneration) between these groups. This retrospective longitudinal cohort study utilized National Alzheimer's Coordinating Center (NACC) data. Participants (N = 856) were required to have moderate-to-severe autopsy-confirmed AD, Clinical Dementia Rating-Global scores of ≤1 at their index visit, and NPS and clinician-rated motor data. Early motor dysfunction was associated with significantly higher NPI-Q total scores (T = 4.48, p < .001) and higher odds of delusions (OR [95%CI]: 1.73 [1.02-2.96]), hallucinations (2.45 [1.35-4.56]), depression (1.51 [1.11-2.06]), irritability (1.50 [1.09-2.08]), apathy (1.70 [1.24-2.36]), anxiety (1.38 [1.01-1.90]), nighttime behaviors (1.98 [1.40-2.81]), and appetite/eating problems (1.56 [1.09-2.25]). Early motor dysfunction was also associated with higher Lewy Body disease pathology (1.41 [1.03-1.93]), but not Frontotemporal Lobar degeneration (1.10 [0.71-1.69]), on autopsy. Our results suggest that motor symptoms in early AD are associated with a higher number and severity of NPS, which may be partially explained by comorbid non-AD neuropathology.


  • Sleepiness in retired male boxers: daytime sleepiness and its relationship with impulsiveness and depression symptomatology in retired professional male boxers

    by Aaron I. Esagoff, Jacob S. Shaw, Michael J.C Bray, Divyaansh Raj, Ashish Vankara, Bharat R. Narapareddy, Charles B. Bernick, Matthew E. Peters

    Background: Boxing exposes fighters to head impacts and potential traumatic brain injury (TBI). Though research has explored the neuropsychiatric consequences of contact sports, there is limited research into Excessive Daytime Sleepiness (EDS) and its relationship to other outcomes, such as impulsiveness and depression. Therefore, this study aimed to describe EDS in retired boxers using the Epworth Sleepiness Scale (ESS) and to examine how boxing and sleepiness relate to impulsiveness and depression symptomatology. Methods: 86 male retired professional boxers from the Professional Fighters Brain Health Study (PFBHS) met the inclusion criteria. Adjusted multivariable models analyzed relationships between professional boxing bouts, EDS (ESS), impulsiveness (Barratt Impulsiveness Scale Version 11 (BIS-11)), and/or depression (Patient Health Questionnaire-9 (PHQ-9)). A causal mediation analysis was performed to assess whether boxing bouts and ESS scores predicted BIS-11 and PHQ-9 scores. Results: Mean age was similar to 51 years, fighters averaged similar to 36 professional bouts, and ESS mean(SD) was 7.5(5.3). ESS scores were significantly associated with raw BIS-11 (Beta = 1.26, 95%CI = 0.77-1.75, p < 0.001) and ordinal PHQ-9 (OR = 1.20, 95%CI = 1.11-1.31, p < 0.001) scores in adjusted models, and the significant relationship between boxing bouts and BIS-11/PHQ-9 was mediated by ESS. Conclusions: EDS in retired male professional boxers may be strongly associated with other neuropsychiatric sequelae of TBI (impulsiveness and depression).